Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-04-26
2011-04-26
Myers, Carla (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007210, C435S091200, C435S091210, C435S091510, C536S023500
Reexamination Certificate
active
07932032
ABSTRACT:
This invention relates to a composition, kit, or DNA chip comprising polynucleotides and antibodies as probes for detecting, determining, or predicting the presence or metastasis of esophageal cancer, and to a method for detecting, determining, or predicting the presence or metastasis of esophageal cancer using the same.
REFERENCES:
patent: 5990299 (1999-11-01), Ruzdijic et al.
patent: 2003/0073105 (2003-04-01), Lasek et al.
patent: 2009/0270267 (2009-10-01), Akiyama et al.
patent: WO-01/74405 (2001-10-01), None
patent: WO-01/94629 (2001-12-01), None
patent: WO-2004/048938 (2004-06-01), None
patent: WO-2005/031001 (2005-04-01), None
Tomatsu et al. Journal Inherited Metabolism Disease. 1994. 17: 601-605.
National Center For Biotechnology Information, National Library of Medicine, NIH (Bethesda, MD, USA) GenBank Accession No. NM—000512, Mar. 23, 2005.
Coleman. Drug Discovery Today. 2003. 8: 233-235.
Liu et al. Clinical Immunology. 2004. 112: 225-230.
Saetre et al. Molecular Brain Research. 2004. 126: 198-206.
GeneCard for GALNS, available via url: <genecards.org/cgi-bin/carddisp.pl?gene=GALNS>, printed Jun. 29, 2010.
Dahlberg et al. Ann Thorac Surg. 2004. 77: 1008-1015.
Kimos et al., “Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression,” Int. J. Cancer, 2004, vol. 111, No. 3, pp. 415-417.
Nemoto T et al.; “Overexpression of Protein Tyrosine Kinases in Human Esophageal Cancer”, Pathobiology, 1997, vol. 65, pp. 195-203, XP009048170.
Ginkel et al., “Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival,” Cancer Res., 2004, vol. 64, No. 1, pp. 128-134.
Su et al., “Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer,” Cancer Res., 2003, vol. 63, No. 14, pp. 3872-3876.
Ebihara et al., “DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma,” Br.J. Cancer, 2004, vol. 91, No. 1, pp. 119-123.
Akiyama Hideo
Kozono Satoko
Myomoto Akira
Nobumasa Hitoshi
Nomura Osamu
Birch, Stewart, Kolasch and Birch LLP
Kyoto University
Myers Carla
Toray Industries Inc.
LandOfFree
Method for diagnosing esophageal cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosing esophageal cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosing esophageal cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2657693